Literature DB >> 25600096

Prostate cancer: Effects of tertiary Gleason pattern 5 on oncological outcome.

Sean R Williamson1, Liang Cheng2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25600096     DOI： 10.1038/nrurol.2014.370

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  9 in total

1.  Original Gleason system versus 2005 ISUP modified Gleason system: the importance of indicating which system is used in the patient's pathology and clinical reports.

Authors:  Rodolfo Montironi; Liang Cheng; Antonio Lopez-Beltran; Marina Scarpelli; Roberta Mazzucchelli; Gregor Mikuz; Ziya Kirkali; Francesco Montorsi
Journal:  Eur Urol       Date:  2010-05-08       Impact factor: 20.096

2.  The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy.

Authors:  Liang Cheng; Michael O Koch; Beth E Juliar; Joanne K Daggy; Richard S Foster; Richard Bihrle; Thomas A Gardner
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

3.  Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer-specific death in patients receiving salvage radiation therapy following radical prostatectomy.

Authors:  William Jackson; Daniel A Hamstra; Skyler Johnson; Jessica Zhou; Benjamin Foster; Corey Foster; Darren Li; Yeohan Song; Ganesh S Palapattu; Lakshmi P Kunju; Rohit Mehra; Felix Y Feng
Journal:  Cancer       Date:  2013-07-02       Impact factor: 6.860

4.  Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic model.

Authors:  Ilaria Lucca; Shahrokh F Shariat; Alberto Briganti; Yair Lotan; Claus G Roehrborn; Francesco Montorsi; Mesut Remzi; Christian Seitz; Harun Fajkovic; Christoph Klingler; Pierre I Karakiewicz; Maxine Sun; Morgan Rouprêt; Wolfgang Loidl; Karl Pummer; Tobias Klatte
Journal:  Urol Oncol       Date:  2014-10-23       Impact factor: 3.498

5.  Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.

Authors:  Eyas M Hattab; Michael O Koch; John N Eble; Haiqun Lin; Liang Cheng
Journal:  J Urol       Date:  2006-05       Impact factor: 7.450

6.  Percentage of Gleason pattern 4 and 5 predicts survival after radical prostatectomy.

Authors:  Liang Cheng; Darrell D Davidson; Haiqun Lin; Michael O Koch
Journal:  Cancer       Date:  2007-11-01       Impact factor: 6.860

7.  Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence.

Authors:  Hong Gee Sim; Donatello Telesca; Stephen H Culp; William J Ellis; Paul H Lange; Lawrence D True; Daniel W Lin
Journal:  J Urol       Date:  2008-03-17       Impact factor: 7.450

8.  Significance of tertiary Gleason pattern 5 in Gleason score 7 radical prostatectomy specimens.

Authors:  Darren E Whittemore; Eric J Hick; Mark R Carter; Judd W Moul; Alejandro J Miranda-Sousa; Wade J Sexton
Journal:  J Urol       Date:  2008-02       Impact factor: 7.450

9.  A tertiary Gleason pattern in the prostatectomy specimen and its association with adverse outcome after radical prostatectomy.

Authors:  Meike Adam; Amir Hannah; Lars Budäus; Thomas Steuber; Georg Salomon; Uwe Michl; Alexander Haese; Margit Fisch; Corinna Wittmer; Stefan Steurer; Sarah Minner; Hans Heinzer; Hartwig Huland; Markus Graefen; Guido Sauter; Thorsten Schlomm; Hendrik Isbarn
Journal:  J Urol       Date:  2014-02-08       Impact factor: 7.450
  9 in total
  1 in total

1.  Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy.

Authors:  Eva Hollemans; Esther I Verhoef; Chris H Bangma; John Rietbergen; Monique J Roobol; Jozien Helleman; Geert J L H van Leenders
Journal:  Histopathology       Date:  2020-04       Impact factor: 5.087
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.